The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal. The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome. With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more。

免疫药理学和免疫毒理学 杂志致力于针对免疫系统的临床前和临床药物发现和开发。研究涉及各种化合物（包括小分子药物和生物制剂）对免疫活性细胞和免疫反应的免疫调节作用，以及异生物质和药物的免疫毒性。该期刊仅对描述特定化合物（而非提取物）机制的研究感兴趣。 该杂志将优先考虑慢性炎症、过敏、自身免疫、癌症等疾病的免疫治疗的临床前和临床研究。小药、疫苗和生物制剂对中枢免疫靶点的影响以及基于细胞的治疗，包括树突状细胞治疗，T细胞过继转移和干细胞治疗，是特别感兴趣的话题。指向免疫系统内潜在新药靶点或免疫药理学药物开发新技术的出版物也受到欢迎